Navigation Links
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Date:11/13/2007

LAGUNA NIGUEL, Calif., Nov. 13 /PRNewswire/ -- Inspiration Biopharmaceuticals announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin clinical trials with IB1001, an intravenous recombinant Factor IX (rFIX) product for the on demand and prophylactic treatment of the bleeding disorder associated with hemophilia B.

Upon FDA approval of the IND application, Inspiration Biopharmaceuticals intends to enter Phase 1/2 clinical trials to evaluate the pharmacokinetics (PK) and safety profile of IB1001, compared with the commercially available Factor IX products; rFIX, BeneFix(R) and plasma-derived Factor, MonoNine(R). Following successful completion of the PK phase of this study, patients will then enroll in one of two trials: a six month Phase 1/2 On Demand trial to document safety and efficacy in treating spontaneous bleeding episodes or a pivotal Phase 2/3 Prophylaxis trial to document safety and efficacy in the prevention of spontaneous bleeding. In addition, the safety and efficacy of peri-surgical prophylactic administration of IB1001 to control bleeding during surgical procedures will be evaluated. The rate of inhibitor formation will be evaluated throughout all phases of the clinical investigation of IB1001.

"We are excited to be filing an IND for IB1001," said Michael Griffith, Ph.D., President and CEO, Inspiration Biopharmaceuticals. "Preclinical studies have demonstrated the expected PK and safety profile for IB1001 when compared to the clinically proven commercial Factor IX products. Our cost-effective manufacturing platform for Factor IX positions Inspiration to expand the global supply of i.v. rFIX and to develop next generation products to facilitate prophylactic care of the hemophilia B patients worldwide. Our ultimate goal is to leverage our low cost manufacturing technology to find the means for non-invasive delivery of Factor IX which we believe may represe
'/>"/>

SOURCE Inspiration Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ) ... specialty pharmaceutical company focused on pharmaceuticals for women,s health, ... Annual ROTH Conference, which will take place from March ... Dana Point, California . Management,s presentation will take ... Time (12:00 p.m. Eastern Time) in the Promenade room. ...
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... addition of the "Global Ultrasound Equipment Market ... The Global Ultrasound Equipment market ... the period 2014-2019 Ultrasound equipment are ... Ultrasound systems are extensively used by cardiologists, radiologists, ...
(Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
Breaking Medicine Technology:Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... Reportlinker.com announces that a new market research report ... Global Orthopedic Prosthetics Industry ... the worldwide markets for Orthopedic Prosthetics in US$ ... Knee Prosthesis, and Secondary Joint Prosthesis (Shoulder Prosthesis, ...
... announces that a new market research report is ... Fluoroscopy And Mobile C-Arms Industry ... the worldwide markets for Fluoroscopy And Mobile C-Arms ... segments: Fluoroscopy, and Mobile C-Arms (Full Size C-Arms, ...
Cached Medicine Technology:Reportlinker Adds Global Orthopedic Prosthetics Industry 2Reportlinker Adds Global Fluoroscopy And Mobile C-Arms Industry 2
(Date:3/3/2015)... 2015 The human augmentation market is ... market. The wearable augmentation sector is predicted to outpace ... the upcoming years. , The eye-wear sector dominates ... big number of new products launches in the region. ... technological advancements as well as the rising demand for ...
(Date:3/3/2015)... March 03, 2015 US Air Purifiers ... air purification systems, is pleased to announce that all Rabbit ... supply interruption related to the west coast port strikes. This ... around the corner. , The port strikes, ... to slow fourth quarter economic growth by as much as ...
(Date:3/3/2015)... The first week of March is Sleep ... event brings recognition to a rarely discussed problem that ... to the Centers for Disease Control , 70 million ... another. Too little or unrestful sleep is associated with ... depression, and even a higher likelihood of obesity. ...
(Date:3/3/2015)... Today is International Ear Care Day, and ... to applaud and promote the launch of Make Listening ... (WHO) for stemming the threat of noise-induced hearing loss. ... to practice safe listening when they recreate, be that ... events, or engaging in other forms of entertainment. ...
(Date:3/3/2015)... The number of couples experiencing infertility ... 15%. This increases to 50% by the time a ... Yuzpe AA, et al. Estimating the prevalence of infertility ... Hitkari, a reproductive endocrinologist and co-director at Olive Fertility ... clinical director and founder of Acubalance Wellness Centre will ...
Breaking Medicine News(10 mins):Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4
... a large review of breast cancer patients with mucinous ... Anderson Cancer Center have identified an association between this ... prognosis and multiple tumors undetected by mammography or ultrasound. ... Antonio Breast Cancer Symposium, is the first to observe ...
... ... in Odessa, Texas , is participating in the popular Toys for Tots program, an annual ... holidays. Donors at Dr. Rutherford’s practice are also entered into a drawing to win a ... ...
... ... Australians on a higher income believe teenagers aged from 15 to 17 year old should be ... , ... of Australian adults and 63 per cent of Australians on a higher income believe teenagers aged ...
... ... the three Monotheistic faiths using an academic model for dissemination and sharing of information ... ... tone of the International Conferences on Bioethics and Religion being held December 13th-14th, 2009 ...
... On ... on tap water quality. The data has been compiled from state environment and health ... database. , ... (Vocus) December 11, 2009 -- On December 12, 2009, the Environmental Working Group (EWG) ...
... , , ... ("Genomma Lab" or "the Company") announces today its,2010 earnings guidance. , ... of 42% to 45% for the,full year of 2010, excluding possible acquisitions, ... we expect to be,above our last issued guidance. , ...
Cached Medicine News:Health News:M. D. Anderson study questions true favorability of rare breast cancer type 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 2Health News:Odessa Texas Cosmetic Dentist Sponsoring Marine Toys for Tots Program to Give Children in Need Free Toys for the Holidays 3Health News:Parents Encourage Underage Drinking 2Health News:Parents Encourage Underage Drinking 3Health News:Parents Encourage Underage Drinking 4Health News:UNESCO Chair Hosts Jews, Christians, and Muslims in Jerusalem Bioethics Conferences 2Health News:UNESCO Chair Hosts Jews, Christians, and Muslims in Jerusalem Bioethics Conferences 3Health News:UNESCO Chair Hosts Jews, Christians, and Muslims in Jerusalem Bioethics Conferences 4Health News:Statement from American Water Works Association on the Environmental Working Group's report on Tap Water Quality Testing and Violations 2
Modified Freer periosteal elevator, #163, strong curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Seldin periosteal elevator #23, flat handle, 19.5 cm, 7-3/4"....
Medicine Products: